NIP
Nicholas Investment Partners’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.89M | Sell |
159,501
-7,154
| -4% | -$309K | 0.61% | 54 |
|
|
2025
Q1 | $5.76M | Buy |
166,655
+106,763
| +178% | +$3.69M | 0.59% | 58 |
|
|
2024
Q4 | $1.64M | Buy |
59,892
+24,248
| +68% | +$665K | 0.14% | 165 |
|
|
2024
Q3 | $907K | Buy |
+35,644
| New | +$907K | 0.08% | 190 |
|
|
2022
Q1 | – | Sell |
-294,879
| Closed | -$4.92M | – | 193 |
|
|
2021
Q4 | $4.92M | Buy |
294,879
+8,747
| +3% | +$146K | 0.31% | 111 |
|
|
2021
Q3 | $13.4M | Sell |
286,132
-165,850
| -37% | -$7.77M | 0.98% | 29 |
|
|
2021
Q2 | $27.6M | Sell |
451,982
-37,641
| -8% | -$2.29M | 1.73% | 2 |
|
|
2021
Q1 | $30.2M | Buy |
489,623
+77,852
| +19% | +$4.8M | 2.1% | 2 |
|
|
2020
Q4 | $29.3M | Buy |
411,771
+118,789
| +41% | +$8.45M | 2.26% | 2 |
|
|
2020
Q3 | $11M | Buy |
292,982
+239,626
| +449% | +$8.99M | 1.19% | 28 |
|
|
2020
Q2 | $1.74M | Sell |
53,356
-7,068
| -12% | -$230K | 0.35% | 104 |
|
|
2020
Q1 | $1.75M | Buy |
60,424
+40,615
| +205% | +$1.18M | 0.34% | 116 |
|
|
2019
Q4 | $694K | Buy |
19,809
+9,624
| +94% | +$337K | 0.07% | 191 |
|
|
2019
Q3 | $219K | Buy |
+10,185
| New | +$219K | 0.02% | 196 |
|